Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors
- PMID: 19915446
- DOI: 10.1097/QAD.0b013e328334444b
Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors
Abstract
Objectives: To determine the prevalence of erectile dysfunction in a cohort of HIV-infected men in a stable clinical state, the effect of exposure to antiretroviral therapy on sexual dysfunction and to identify the risk factors.
Design: This is a cross-sectional, observational study.
Methods: HIV-infected men without hepatitis C virus coinfection were included if they were antiretroviral therapy-naive (naive group), on current treatment with an enhanced protease inhibitor (protease inhibitor group) or on current treatment with two to three nucleoside reverse transcriptase inhibitors along with one nonnucleoside reverse transcriptase inhibitor and never having received treatment with protease inhibitor (nonnucleoside reverse transcriptase inhibitor group). Erectile dysfunction was defined as an ejection fraction of 25 or less (International Index of Erectile Function-15).
Results: Ninety patients were included, with an age of 42 +/- 8.2 years and CD4 cell count of 465 cells/microl [P25-75 361-676]: 18.9% in Centers for Disease Control and Prevention class C and 72.2% with undetectable viral load. Seventy-six patients (84.4%) were receiving antiretroviral therapy, 39 (43.3%) in the protease inhibitor group. The prevalence of lipodystrophy was 31.5%. Forty-seven (53.4%) patients had an erectile dysfunction. Multivariate logistic regression analysis confirmed that there was an independent association between the patients' age (per decade; odds ratio 2.2, 95% confidence interval 1.04-4.5, P = 0.04) and greater duration of exposure to protease inhibitor (per year; odds ratio 1.6, 95% confidence interval 1.12-2.4, P = 0.01). Older age, depression and lipodystrophy, combined with the duration of exposure to protease inhibitor, determined a lower score on various sexual dysfunction domains (P < 0.05).
Conclusion: There is a high prevalence of erectile dysfunction in HIV-infected men, with age and the duration of exposure to protease inhibitor being the only identifiable risk factors.
Similar articles
-
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.AIDS. 2003 May 23;17(8):1179-93. doi: 10.1097/01.aids.0000060358.78202.c1. AIDS. 2003. PMID: 12819520
-
HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.AIDS. 2009 Mar 13;23(5):589-96. doi: 10.1097/QAD.0b013e328325a87c. AIDS. 2009. PMID: 19177019
-
Side effects. Sexual dysfunction in men: a report from Boston.TreatmentUpdate. 2002 Jul;14(5):4-5. TreatmentUpdate. 2002. PMID: 12141282 No abstract available.
-
Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.J Am Acad Dermatol. 2010 Oct;63(4):549-61; quiz 561-2. doi: 10.1016/j.jaad.2010.01.061. J Am Acad Dermatol. 2010. PMID: 20846563 Review.
-
[HIV infection, antiretroviral therapy, and endothelium].Herz. 2005 Sep;30(6):472-80. doi: 10.1007/s00059-005-2740-3. Herz. 2005. PMID: 16170677 Review. German.
Cited by
-
Update on acquired hypogonadism in men living with HIV: pathogenesis, clinic, and treatment.Front Endocrinol (Lausanne). 2023 Jun 26;14:1201696. doi: 10.3389/fendo.2023.1201696. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455928 Free PMC article. Review.
-
Sexual Dysfunctions Among People Living With HIV With Long-Term Treatment With Antiretroviral Therapy.Sex Med. 2022 Oct;10(5):100542. doi: 10.1016/j.esxm.2022.100542. Epub 2022 Jul 21. Sex Med. 2022. PMID: 35870269 Free PMC article.
-
Psychosocial risk factors of erectile dysfunction among heterosexual men living with HIV.AIDS Care. 2023 Feb;35(2):253-260. doi: 10.1080/09540121.2022.2039357. Epub 2022 Feb 8. AIDS Care. 2023. PMID: 35135404 Free PMC article.
-
HIV and Sexual Dysfunction in Men.J Clin Med. 2021 Mar 5;10(5):1088. doi: 10.3390/jcm10051088. J Clin Med. 2021. PMID: 33807833 Free PMC article. Review.
-
Sexual (Dis)satisfaction and Its Contributors Among People Living with HIV Infection in Sweden.Arch Sex Behav. 2018 Oct;47(7):2007-2026. doi: 10.1007/s10508-017-1106-2. Epub 2018 Feb 13. Arch Sex Behav. 2018. PMID: 29441436 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials